Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate 71335-1858
Product NDC
71335-1858- Manufacturer
- Bryant Ranch Prepack
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- January 22, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA209069
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
| Naloxone Hydrochloride Dihydrate | 2 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Packaging Options(10)
42 TABLET in 1 BOTTLE, PLASTIC (71335-1858-0)
30 TABLET in 1 BOTTLE, PLASTIC (71335-1858-1)
60 TABLET in 1 BOTTLE, PLASTIC (71335-1858-2)
90 TABLET in 1 BOTTLE, PLASTIC (71335-1858-3)
120 TABLET in 1 BOTTLE, PLASTIC (71335-1858-4)
14 TABLET in 1 BOTTLE, PLASTIC (71335-1858-5)
28 TABLET in 1 BOTTLE, PLASTIC (71335-1858-6)
6 TABLET in 1 BOTTLE, PLASTIC (71335-1858-7)
10 TABLET in 1 BOTTLE, PLASTIC (71335-1858-8)
21 TABLET in 1 BOTTLE, PLASTIC (71335-1858-9)
External Resources